Products
Diabetes is personal. For more than 30 million people in over 100 countries, embecta is the trusted choice.
- Overview
We have been one of the leaders in insulin delivery for nearly 100 years. Today, through our insulin-delivery products, we touch an estimated 30 million people living with diabetes in over 100 countries.²
For nearly 100 years, we’ve been making insulin delivery simpler and more comfortable for people around the world. We know your diabetes experience is unique to you, and — no matter what your treatment plan looks like — you should never have to face diabetes alone. With a singular focus on improving the lives of people living with diabetes, embecta offers a wide variety of insulin-delivery devices and comprehensive care resources to best fit your needs:
- Shorter pen needles, for example 4mm, are the recommended needle length for patients and for all injection sites.*
- Insulin syringe portfolio offering that accommodates various patient needs
- A variety of educational resources help with your day-to-day management of diabetes
* American Diabetes Association. Standards of Medical Care in Diabetes—2020. DiabetesCare.2020;43(suppl 1):S1-S212.
-
Pen Needles
Our products are diligently designed to enable people who are living with diabetes to benefit from comfortable, effective diabetes care
Learn More
-
Insulin Syringes
Portfolio of needle lengths and barrel sizes designed to help to meet the needs of people with diabetes
Learn More
- Whooley S, Briskin T, Gibney MA, Blank LR, Berube J, Pflug BK. Evaluating the user performance and experience with a re-engineered 4mm × 32G pen needle: a randomised trial with similar length/gauge needles. Diabetes Ther. 2019;10(2):697-712.
- Data on file. embecta market model. 2021